I wonder if PYC is considering updating its website. Perhaps that could be next year’s/next month’s project.
If I were to go to the website as a prospective investor I would learn that PYC’s strategy is providing peptide drug discovery partnerships, based on its proprietary Phylomer libraries and screening technologies, to pharmaceutical and biotechnology companies. Shame the strategy isn’t dated by year, if not by month.
If I were to then check PYC’s pharmaceutical partners on the website, I wouldn’t learn about PYC’s partnership with Genentech. That’s because it’s not there. Perhaps PYC won’t need to bother updating that page because Genentech might have become past history before it even becomes current history on the website.
If I was to scan PYC’s technology partners, there would be zero chance of me becoming excited about PhoreMost and IMB. That’s because they’re not mentioned.
What about the competitive advantages of cell-penetrating peptides using endosome escape technology? I wouldn’t learn about that either, as it’s not mentioned as a technology and it’s not mentioned as a competitive advantage. In fact, it’s not even mentioned, yet alone explained.
Oh dear! PYC, perhaps you could skip a few conferences next year and put the money towards dragging your website into 2016.
PYC Price at posting:
1.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)